Harvest Investment Services, LLC Verastem, Inc. Transaction History

Harvest Investment Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$2.05 - $3.2 $21,166 - $33,040	-10,325 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$2.54 - $4.07 $957 - $1,534	-377 Reduced 3.52%	10,325 $31,000
Q2 2021 Aug 10, 2021	SELL	$2.57 - $4.85 $1,205 - $2,274	-469 Reduced 4.2%	10,702 $43,000
Q1 2021 May 06, 2021	SELL	$1.9 - $2.82 $364 - $541	-192 Reduced 1.69%	11,171 $27,000
Q4 2020 Feb 01, 2021	SELL	$1.15 - $2.4 $108 - $225	-94 Reduced 0.82%	11,363 $24,000
Q3 2020 Oct 29, 2020	SELL	$1.11 - $1.68 $685 - $1,038	-618 Reduced 5.12%	11,457 $13,000
Q2 2020 Aug 11, 2020	BUY	$1.69 - $4.2 $20,406 - $50,715	12,075 New	12,075 $20,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.25B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Investment Services, LLC with notifications on news.